Interstitial lung disease with systemic sclerosis
Clinical trials for Interstitial lung disease with systemic sclerosis explained in plain language.
Never miss a new study
Get alerted when new Interstitial lung disease with systemic sclerosis trials appear
Sign up with your email to follow new studies for Interstitial lung disease with systemic sclerosis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Drug combo aims to halt lung scarring in scleroderma
Disease control Recruiting nowThis trial tests whether adding rituximab to standard mycophenolate mofetil (MMF) therapy can improve lung function in people with severe lung scarring caused by systemic sclerosis. About 102 adults with this condition will receive either rituximab infusions plus MMF or placebo i…
Matched conditions: INTERSTITIAL LUNG DISEASE WITH SYSTEMIC SCLEROSIS
Phase 3 • Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Scleroderma's hidden link: could pelvic floor trouble track with weaker lungs?
Knowledge-focused Recruiting nowScleroderma often scars the lungs, which can weaken breathing muscles and make exercise harder. Researchers want to know whether pelvic floor problems, such as incontinence or pelvic pain, go hand in hand with these lung and breathing changes. The study enrolls 67 women with scle…
Matched conditions: INTERSTITIAL LUNG DISEASE WITH SYSTEMIC SCLEROSIS
Sponsor: Biruni University • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC